Share in X

Closed System Transfer Device Market Size, Share, Trend, Forecast Report 2026 to 2035

Report ID: 3701 Pages: 180 Updated: 18 August 2026 Format: PDF / PPT / Excel / Power BI

What is Closed System Transfer Device Market Size?

Global Closed System Transfer Device Market Size is valued at USD 1.51 Bn in 2025 and is predicted to reach USD 7.46 Bn by the year 2035 at a 17.5% CAGR during the forecast period for 2026 to 2035.

Closed System Transfer Device Market Size, Share & Trends Analysis Distribution by Type (Needless Systems, Membrane to Membrane Systems), By Closing Mechanism (Colour to Colour Alignment Systems, Lueker Lock Systems, Push to Turn systems, Click to Lock Systems), By Component (Syringe Safety Devices, Vial Access Devices, Bag Access Devices, Other), By Technology (Compartmentalize Devices, Diaphragm Based Devices, Air Filtration Devices), By End Use (Hospitals & Clinics,Ambulatory Surgery Centres, Research Laboratories, Others) and Segment Forecasts, 2026 to 2035.

Closed System Transfer Device Market

A closed system transfer device (CSTD) is a specialized drug-transfer system. It is designed to prevent the escape of hazardous drugs or vapors into the surrounding environment. The device also stops environmental contaminants from entering the sterile drug pathway. CSTDs are mainly used during the preparation, transfer, administration, and disposal of hazardous medications. This is particularly important for antineoplastic and other cytotoxic drugs used in oncology treatment. By keeping the transfer process sealed, CSTDs protect healthcare professionals, patients, and pharmacists from accidental exposure to hazardous substances. They also maintain drug sterility throughout the handling process. CSTDs come in various configurations, including membrane-to-membrane, needle-free, and air-cleaning technologies. Hospitals, oncology centers, ambulatory infusion clinics, and specialty pharmacies are increasingly adopting CSTDs to improve medication safety and support standardized drug handling practices. 

The global closed system transfer device market includes manufacturers and suppliers of systems and accessories. These are used for the safe handling of hazardous drugs in healthcare settings. The market features vial access devices, syringe safety components, bag and line access devices, transfer adapters, and related consumables. These products are compatible with many injectable drug delivery systems. The market is growing due to the rising adoption of hazardous drug safety protocols, increased oncology treatment volumes, and a stronger focus on workplace safety in healthcare facilities. Ongoing product innovation, better device compatibility with existing infusion systems, and the integration of new sealing and contamination-control technologies are shaping the competitive landscape. Additionally, the growth of healthcare infrastructure, the rising use of injectable specialty pharmaceuticals, and increasing regulatory attention to safe drug handling practices are driving the adoption of closed system transfer devices in both developed and emerging healthcare markets.

Competitive Landscape

Which are the Leading Players in the Closed System Transfer Device Market?

  • Becton, Dickinson and Company (BD)
  • ICU Medical, Inc.
  • EQUASHIELD LLC
  • Simplivia Healthcare Ltd.
  • B. Braun Melsungen AG
  • Yukon Medical, LLC
  • CORMED, Inc. — HALO
  • JMS Co., Ltd.
  • Terumo Corporation
  • Eraser Medical / Eraser Medikal Ltd. Şti.
  • CODAN Medizinische Geräte GmbH & Co. KG
  • Vygon SA.

Market Dynamics

Driver

Growing Adoption of Hazardous Drug Safety Practices 

Healthcare professionals involved in preparing and administering hazardous drugs, including pharmacists, nurses, and technicians, are at risk of accidental exposure to aerosols, vapors, spills, and leaks. Closed System Transfer Devices are designed to reduce these risks by preventing hazardous drug contaminants from escaping and stopping environmental contaminants from entering during drug transfer. As cancer cases continue to rise globally and the use of injectable oncology therapies increases, hospitals, cancer centers, and specialty pharmacies are adopting CSTDs more frequently as part of safe drug handling practices. Furthermore, following occupational safety standards and guidelines for hazardous drug handling, like USP <800> in the United States and similar recommendations from organizations like NIOSH, has sped up the use of CSTDs in healthcare facilities. 

Restrain/Challenge

High Cost of Closed System Transfer Devices 

CSTDs cost much more than traditional drug transfer devices. This raises the overall expenses of preparing and giving chemotherapy. The ongoing costs of disposable parts, compatibility adapters, and replacement items can create a heavy financial strain on hospitals, oncology clinics, and pharmacies, especially in low- and middle-income countries. Budget limits, issues with reimbursement, and the need to work with existing infusion systems can slow down adoption, particularly in smaller healthcare facilities.

Membrane to Membrane Systems Segment is Expected to Drive the Closed System Transfer Device Market

Membrane-to-Membrane Systems are expected to drive the closed system transfer device (CSTD) Market during the forecast period. This is due to their excellent ability to keep a completely closed and sterile drug transfer process. They reduce the risk of hazardous drug leakage and microbial contamination. Their high containment efficiency, adherence to hazardous drug handling standards, and broad use in hospital pharmacies and oncology settings for safely preparing and administering hazardous medications are likely to support segment growth. 

Click to Lock Systems Segment is Growing at the Highest Rate in the Closed System Transfer Device Market

Click-to-Lock Systems are expected to see the fastest growth in the closed system transfer device (CSTD) Market during the forecast period. This growth is due to their safe and easy-to-use locking mechanism, which reduces accidental disconnections, toxic drug leaks, and user mistakes while ensuring reliable drug containment. Their rising use in hospitals, oncology centers, and pharmacy compounding facilities, driven by the need for safer and more efficient ways to handle hazardous drugs, is likely to boost significant segment growth. 

Why North America Led the Closed System Transfer Device Market?

North America is set to lead the closed system transfer device (CSTD) market during the forecast period. This is due to strict regulatory requirements for handling hazardous drugs, a growing awareness of safe medication practices, and the widespread use of CSTDs in healthcare facilities.

Closed System Transfer Device Market

The region has a strong healthcare infrastructure, high spending on healthcare, and compliance with guidelines from organizations like NIOSH and USP <800>. Furthermore, the presence of major manufacturers, including Becton, Dickinson and Company (BD), along with ongoing product innovation and a wide range of available products, is likely to enhance the region's market leadership. 

Closed System Transfer Device Market Report Scope:

Report Attribute Specifications
Market size value in 2025 USD 1.51 Bn
Revenue forecast in 2035 USD 7.46 Bn
Growth Rate CAGR CAGR of 17.5% from 2026 to 2035
Quantitative Units Representation of revenue in US$ Bn and CAGR from 2026 to 2035
Historic Year 2022 to 2025
Forecast Year 2026-2035
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered Type, Closing Mechanism, Component, Technology, End Use and By Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia
Competitive Landscape BD, ICU Medical, Inc., EQUASHIELD, B. Braun Melsungen AG,  Simplivia Healthcare Ltd., Corvida Medical, Yukon Medical, JMS Co., Ltd.,
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape.                     
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

 

Segmentations of Closed System Transfer Device Market:

Closed System Transfer Device Market by Type -

  • Needless Systems
  • Membrane to Membrane Systems

Closed System Transfer Device Market

Closed System Transfer Device Market by Closing Mechanism -

  • Colour to Colour Alignment Systems
  • Lueker Lock Systems
  • Push to Turn systems
  • Click to Lock Systems

Closed System Transfer Device Market by Component -

  • Syringe Safety Devices
  • Vial Access Devices
  • Bag Access Devices
  • Other

Closed System Transfer Device Market by Technology -

  • Compartmentalize Devices
  • Diaphragm Based Devices
  • Air Filtration Devices

Closed System Transfer Device Market by End Use -

  • Hospitals & Clinics
  • Ambulatory Surgery Centres
  • Research Laboratories
  • Others

Closed System Transfer Device Market by Region-

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Request Customization

Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.

Customize This Report →

Enquire Before Buying

Speak with our analyst team about scope, methodology, pricing, or deliverable formats.

Enquire Now →

Frequently Asked Questions

How big is the Closed System Transfer Device Market Size?

Closed System Transfer Device Market Size is valued at USD 1.51 Bn in 2025 and is predicted to reach USD 7.46 Bn by the year 2035.

What is the Closed System Transfer Device Market Growth?

The Closed System Transfer Device Market is expected to grow at a 17.5% CAGR during the forecast period for 2026 to 2035.

Who are the key players in the Closed System Transfer Device Market?

BD, ICU Medical, Inc., EQUASHIELD, B. Braun Melsungen AG, Simplivia Healthcare Ltd., Corvida Medical, Yukon Medical, JMS Co., Ltd., and Others.

What are the key segments of the Closed System Transfer Device Market?

Closed System Transfer Device Market is segmented into Type, Closing Mechanism, Component, Technology, End Use and Other.

Which region is leading the Closed System Transfer Device Market?

North America region is leading the Closed System Transfer Device Market.

FREE SAMPLE REPORT

Get Your Market Report Sample

See the data, methodology, and competitive landscape preview & delivered to your inbox shortly.

Check your inbox shortly after submitting. If you don't see our email, please check your External, Spam, Junk, or Promotions folder.

Trusted by Sartorius, L'Oreal, Fujifilm & 370+ organizations

KOL-Validated Research Analyst-Built Models Direct Analyst Access
Send me Sample Report Request for Customization